TruBridge, Inc. (NASDAQ:TBRG – Get Free Report) was the target of a large growth in short interest in the month of March. As of March 31st, there was short interest totalling 564,400 shares, a growth of 20.2% from the March 15th total of 469,400 shares. Based on an average daily trading volume, of 179,300 shares, the days-to-cover ratio is presently 3.1 days. Currently, 4.0% of the shares of the stock are short sold.
TruBridge Price Performance
Shares of NASDAQ TBRG opened at $24.29 on Monday. The company has a market capitalization of $363.04 million, a price-to-earnings ratio of -5.94, a PEG ratio of 5.38 and a beta of 0.64. The company has a debt-to-equity ratio of 1.00, a current ratio of 1.80 and a quick ratio of 1.78. TruBridge has a 1-year low of $7.61 and a 1-year high of $32.00. The business has a 50-day moving average of $27.27 and a 200-day moving average of $21.29.
Insider Activity
In other TruBridge news, major shareholder Pinetree Capital Ltd. acquired 6,795 shares of the stock in a transaction that occurred on Tuesday, February 18th. The shares were purchased at an average cost of $28.16 per share, with a total value of $191,347.20. Following the purchase, the insider now owns 729,176 shares in the company, valued at approximately $20,533,596.16. The trade was a 0.94 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, CEO Christopher L. Fowler sold 5,100 shares of the company’s stock in a transaction that occurred on Friday, March 14th. The shares were sold at an average price of $27.02, for a total value of $137,802.00. Following the completion of the sale, the chief executive officer now directly owns 142,939 shares in the company, valued at approximately $3,862,211.78. The trade was a 3.45 % decrease in their position. The disclosure for this sale can be found here. Insiders acquired 116,728 shares of company stock valued at $3,239,879 in the last three months. 10.70% of the stock is currently owned by company insiders.
Institutional Inflows and Outflows
Analysts Set New Price Targets
TBRG has been the topic of several research analyst reports. Stephens reissued an “equal weight” rating and issued a $28.00 target price on shares of TruBridge in a research report on Thursday, April 10th. Cantor Fitzgerald boosted their price target on TruBridge from $20.00 to $29.00 and gave the company an “overweight” rating in a research report on Tuesday, March 11th.
View Our Latest Report on TBRG
TruBridge Company Profile
TruBridge, Inc provides healthcare solutions and services for community hospitals, clinics, and other healthcare systems in the United States and internationally. The company operates in three segments: Revenue Cycle Management (RCM), Electronic Health Record (HER), and Patient Engagement. It focuses on providing RCM solutions for care settings, regardless of primary healthcare information solutions provider along with business management, consulting, managed IT services, and analytics and business intelligence.
Further Reading
- Five stocks we like better than TruBridge
- Technology Stocks Explained: Here’s What to Know About Tech
- This Volatile Market is Made For Nickel and Diming These Names
- What is a buyback in stocks? A comprehensive guide for investors
- Gold is Making All-Time Highs, But So is This Quiet Metal
- What is a support level?
- D-Wave Quantum Slides on Chip News: Opportunity to Buy?
Receive News & Ratings for TruBridge Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TruBridge and related companies with MarketBeat.com's FREE daily email newsletter.